{"id":"W2346817266","doi":"10.1016/j.clml.2016.04.012","title":"Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Prednisone; Cyclophosphamide; Tolerability; Dexamethasone; Regimen; Internal medicine; Multiple myeloma; Refractory (planetary science); Gastroenterology; Peripheral neuropathy; Surgery; Chemotherapy; Adverse effect; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004270603,0.0003705125,0.001093618,0.0005939306,0.0004488867,0.0003145849,0.00061574,0.0004834749,0.001945122],"category_scores_gemma":[0.000468131,0.0001495505,0.0007478319,0.0006293902,0.0002896932,0.000300869,0.000301021,0.001367226,0.0004758764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006306773,"about_ca_system_score_gemma":0.0009942704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728745,"about_ca_topic_score_gemma":0.006964574,"domain_scores_codex":[0.999814,0.00005305456,0.0000223852,0.00002059375,0.00004169621,0.00004822681],"domain_scores_gemma":[0.9998587,0.00002722088,0.0000271493,0.00001067168,0.000009661298,0.00006653625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04432302,0.003733652,0.007371304,0.001612821,0.001198082,0.004448646,0.000194664,0.001459659,0.01753212,0.001191518,0.01461583,0.9023187],"study_design_scores_gemma":[0.1951233,0.103988,0.2985011,0.002664796,0.005073777,0.0478917,0.0006899067,0.008222392,0.03319904,0.006712392,0.297611,0.0003226475],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7354039,0.2380148,0.001328286,0.004440169,0.001571646,0.000610112,0.0006135719,0.0002804059,0.01773719],"genre_scores_gemma":[0.9468631,0.04436172,0.001895205,0.001352645,0.0006913877,0.0001793102,0.0005385462,0.0000238117,0.00409439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001945122,"threshold_uncertainty_score":0.006507039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05131108994435344,"score_gpt":0.344220347304109,"score_spread":0.2929092573597555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}